US 11033631
Methods of treating CYP2D6 alternative metabolizers
granted A61KA61K47/60A61P
Quick answer
US patent 11033631 (Methods of treating CYP2D6 alternative metabolizers) held by Nektar Therapeutics expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K47/60, A61P, A61P3/00, A61P43/00